Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-2-5
pubmed:abstractText
African trypanosomiasis is a deadly disease for which few chemotherapeutic options are available. The causative agents, Trypanosoma brucei rhodesiense and T. b. gambiense, utilize a non-cytochrome, alternative oxidase (AOX) for their cellular respiration. The absence of this enzyme in mammalian cells makes it a logical target for therapeutic agents. We designed three novel compounds, ACB41, ACD15, and ACD16, and investigated their effects on trypanosome alternative oxidase (TAO) enzymatic activity, parasite respiration, and parasite growth in vitro. All three compounds contain a 2-hydroxybenzoic acid moiety, analogous to that present in SHAM, and a prenyl side chain similar to that found in ubiquinol. ACD15 and ACD16 are further differentiated by the presence of a solubility-enhancing carbohydrate moiety. Kinetic studies with purified TAO show that all three compounds competitively inhibit TAO, and two compounds, ACB41 and ACD15, have inhibition constants five- and three-fold more potent than SHAM, respectively. All three compounds inhibited the respiration and growth of continuously cultured T. b. brucei bloodstream cells in a dose-dependent manner. None of the compounds interfered with respiration of rat liver mitochondria, nor did they inhibit the growth of a continuously cultured mammalian cell line. Collectively, the results suggest we have identified a new class of compounds that are inhibitors of TAO, have trypanocidal properties in vitro, and warrant further investigation in vivo.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carbohydrates, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glucosides, http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases, http://linkedlifedata.com/resource/pubmed/chemical/Plant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Protozoan Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Salicylamides, http://linkedlifedata.com/resource/pubmed/chemical/Salicylic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Salicylic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Trypanocidal Agents, http://linkedlifedata.com/resource/pubmed/chemical/alternative oxidase
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0001-706X
pubmed:author
pubmed:issnType
Print
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
172-84
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17126803-Animals, pubmed-meshheading:17126803-Carbohydrates, pubmed-meshheading:17126803-Cell Line, pubmed-meshheading:17126803-Dose-Response Relationship, Drug, pubmed-meshheading:17126803-Drug Design, pubmed-meshheading:17126803-Enzyme Inhibitors, pubmed-meshheading:17126803-Glucosides, pubmed-meshheading:17126803-Mice, pubmed-meshheading:17126803-Mitochondrial Proteins, pubmed-meshheading:17126803-Oxidoreductases, pubmed-meshheading:17126803-Plant Proteins, pubmed-meshheading:17126803-Protozoan Proteins, pubmed-meshheading:17126803-Rats, pubmed-meshheading:17126803-Salicylamides, pubmed-meshheading:17126803-Salicylic Acid, pubmed-meshheading:17126803-Salicylic Acids, pubmed-meshheading:17126803-Trypanocidal Agents, pubmed-meshheading:17126803-Trypanosoma brucei brucei
pubmed:year
2006
pubmed:articleTitle
Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
pubmed:affiliation
Vanderbilt University School of Medicine, Department of Microbiology and Immunology, Nashville, TN 37232, United States.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural